Logo image of AHPI

ALLIED HEALTHCARE PRODUCTS (AHPI) Stock Earnings & Estimates

NASDAQ:AHPI - US0192222075 - Common Stock

0.5501 USD
+0.02 (+3.58%)
Last: 2/2/2023, 8:00:00 PM
0.53 USD
-0.02 (-3.65%)
After Hours: 2/2/2023, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022
Revenue
YoY % growth
AHPI revenue by date.AHPI revenue by date.
31.9M
1.59%
36.279M
13.73%
27.047M
-25.45%
EBITDA
YoY % growth
AHPI ebitda by date.AHPI ebitda by date.
-2.48M
-25.25%
52.65K
102.12%
-4.129M
-7,941.79%
EBIT
YoY % growth
AHPI ebit by date.AHPI ebit by date.
-3.1M
-10.71%
-526.82K
83.01%
-4.58M
-769.36%
Operating Margin
AHPI operating margin by date.AHPI operating margin by date.
-9.72%-1.45%-16.93%
EPS
YoY % growth
AHPI eps by date.AHPI eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
6.015M
-14.32%
%
Q3 2022
Q2Q % growth
6.867M
-13.84%
%
Q2 2022
Q2Q % growth
6.807M
-38.67%
%
Q1 2022
Q2Q % growth
7.358M
-27.80%
%
Q4 2021
Q2Q % growth
7.019M
-17.52%
%
Q3 2021
Q2Q % growth
7.97M
-1.60%
%
Q2 2021
Q2Q % growth
11.1M
51.85%
%
Q1 2021
Q2Q % growth
10.19M
27.69%
%
Q4 2020
Q2Q % growth
8.51M
10.66%
%
Q3 2020
Q2Q % growth
8.1M
-2.64%
%
Q2 2020
Q2Q % growth
7.31M
-9.86%
%
Q1 2020
Q2Q % growth
7.98M
9.77%
%
AHPI Yearly Revenue VS EstimatesAHPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A